Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Pharmaceutical Research|May 5, 1999
Population pharmacokinetics of tirilazad: effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhageJ C Fleishaker, J Fiedler-Kelly, T H GraselaJournal of Clinical Pharmacology|July 1, 1997
Dose proportionality of cisatracuriumV D Schmith, J Fiedler-Kelly, L Phillips, et al.Pharmaceutical Research|January 1, 1997
Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracuriumV D Schmith, J Fiedler-Kelly, L Phillips, et al.Antimicrobial Agents and Chemotherapy|August 20, 2014
Tedizolid population pharmacokinetics, exposure response, and target attainmentS Flanagan, J Passarell, Q Lu, et al.CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
Population Pharmacokinetic and Pharmacodynamic Modeling of LY2510924 in Patients With Advanced CancerS Bihorel, E Raddad, J Fiedler-Kelly, et al.Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
A nationwide survey of clinical laboratory methodologies for fungal infectionsS D Goodwin, J Fiedler-Kelly, T H Grasela, et al.Clinical Pharmacology and Therapeutics|November 11, 1992
Population pharmacodynamics of doxacuriumV D Schmith, J Fiedler-Kelly, M Abou-Donia, et al.Journal of Clinical Pharmacology|April 10, 1999
Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsyT H Grasela, J Fiedler-Kelly, E Cox, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 14, 2001
Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessationJ A Johnston, J Fiedler-Kelly, E D Glover, et al.Acta Neurologica Scandinavica|May 8, 2018
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetateB E Gidal, M P Jacobson, E Ben-Menachem, et al.Pageof 1